
14/09/2025
AHIP warns 2026 premiums face pressure from medical inflation, drug costs, regulatory shifts & a potential end to enhanced tax credits—with Open Enrollment on Nov 1. Meanwhile, CSRxP: generics/biosimilars saved $467B in 2024. Congress should act.
🔗
Each year, health plans are required to submit proposed premium rates to state and federal regulators based on projected future health insurance costs for…